Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Parents, clinicians press committee for THC potency caps, stronger warnings and better data collection
Summary
A stream of parents, clinicians and public‑health advocates told the Joint Committee on Cannabis Policy that high‑potency THC products are linked to cannabis‑induced psychosis, addiction and other harms, and urged passage of bills that would require clearer warning labels, set potency limits and improve data collection.
Parents, physicians and public‑health advocates urged the Joint Committee on Cannabis Policy on Tuesday to act on a package of public‑health bills that would add clearer warnings, require broader data collection and set product potency limits.
Amy Turncliff, a neuroscientist who said she coordinates public‑health statements on cannabis, told the committee she has collected clinician and parent testimonies describing “cannabis‑induced psychosis” and urged warning labels and data collection. "We literally say there is limited information on the side effects of using this product," she testified. "We are in desperate need of an omnibus bill that focuses on prioritizing public health."
Multiple speakers asked for potency limits.…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
